1996
Life Sciences
Medical Devices
Loteprednol etabonate – tobramcyin: A Novel Steriod/Antibiotic
Bausch & Lomb (blp) Inc.
TAMPA (Florida)
Pharmos Ltd.
REHOVOT (Tel Aviv & Central)
Project description
The joint development of ‘loteprednol etabonate’ (LE) by Pharmos and Bausch & Lomb, funded by the BIRD Foundation, resulted in…
Read More
The joint development of ‘loteprednol etabonate’ (LE) by Pharmos and Bausch & Lomb, funded by the BIRD Foundation, resulted in the fundamental formulation for the development of Lotemax, the No. 1 dispensed ophthalmic steroid brand in America, and Alrex, the treatment of choice among many eye-care professionals in the United States for severe seasonal allergic conjunctivitis.
Read Less#789